Concepedia

Courtney DiNardo

CD

3

Publications

938

Citations

3

H-Index

2013

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Emory University

Baylor College of Medicine

Georgia Institute of Technology

Courtney DiNardo is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, medicine, and tumor biology.

Top concepts

MedicineImmunologyCell BiologyTumor BiologyPathologyCell DeathHematologyImmunotherapyCancer Research

Publications per year

2013–2017

3

Publications

3

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

Hui Yang, Carlos E. Bueso‐Ramos, Courtney DiNardo et al. · Leukemia · 2013 · 670 citations · Full text

Hematological Malignancy, Bone Marrow Failure, Hematology +5

Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells

Dyana T. Saenz, Warren Fiskus, Yimin Qian et al. · Leukemia · 2017 · 179 citations · Full text

Hematological Malignancy, Novel Bet, Superior Lethal Activity +8

BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells

Dyana T. Saenz, Warren Fiskus, Taghi Manshouri et al. · Leukemia · 2016 · 89 citations · Full text

Hematological Malignancy, Inhibitor-based Combinations, Bet Protein +8

Rows per page

1–3 of 3